KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atomera (ATOM) Liabilities and Shareholders Equity (2016 - 2026)

Atomera has reported Liabilities and Shareholders Equity over the past 11 years, most recently at $21.1 million for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 27.58% to $21.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $93.4 million through Dec 2025, down 0.74% year-over-year, with the annual reading at $21.1 million for FY2025, 27.58% down from the prior year.
  • Liabilities and Shareholders Equity was $21.1 million for Q4 2025 at Atomera, down from $21.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $39.7 million in Q3 2021 and troughed at $20.1 million in Q3 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $26.5 million (2022), against an average of $27.8 million.
  • Year-over-year, Liabilities and Shareholders Equity surged 223.31% in 2021 and then tumbled 31.42% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $36.1 million in 2021, then dropped by 25.88% to $26.7 million in 2022, then decreased by 10.1% to $24.0 million in 2023, then grew by 21.2% to $29.1 million in 2024, then fell by 27.58% to $21.1 million in 2025.
  • Per Business Quant, the three most recent readings for ATOM's Liabilities and Shareholders Equity are $21.1 million (Q4 2025), $21.9 million (Q3 2025), and $24.1 million (Q2 2025).